000 01597 a2200385 4500
005 20250514061255.0
264 0 _c20030930
008 200309s 0 0 eng d
022 _a0947-7349
024 7 _a10.1055/s-2003-37495
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchütt, M
245 0 0 _aThe HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells.
_h[electronic resource]
260 _bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
_cFeb 2003
300 _a16-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCarcinoma, Hepatocellular
_xenzymology
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlycogen
_xbiosynthesis
650 0 4 _aHIV Protease Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aIndinavir
_xpharmacology
650 0 4 _aInsulin
_xpharmacology
650 0 4 _aLiver
_xdrug effects
650 0 4 _aLiver Neoplasms
_xenzymology
650 0 4 _aProtein Tyrosine Phosphatases
_xmetabolism
650 0 4 _aStimulation, Chemical
650 0 4 _aTumor Cells, Cultured
700 1 _aMeier, M
700 1 _aJost, M M
700 1 _aKlein, H H
773 0 _tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
_gvol. 111
_gno. 1
_gp. 16-20
856 4 0 _uhttps://doi.org/10.1055/s-2003-37495
_zAvailable from publisher's website
999 _c12401635
_d12401635